A rare and fatal brain disorder with no available treatment or cure. One that attacks the nervous system, balance, and the ability to move.

Earlier this month, MSA Safety Inc. elected longtime director Robert A. Bruggeworth as Chairman of the Board, replacing Nish ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

At FDIC International this week, MSA Safety is showing the G1 XR™ Edition Self-Contained Breathing Apparatus (SCBA). Designed directly from firefighter feedback, this next-generation SCBA addresses ...

MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced industrial safety technology products and solutions that protect people and facility infrastructure, today announced ...

MSA Safety Incorporated (MSA) is expected to announce a dividend increase, continuing its 25-year streak of regular dividend growth. The company last paid a dividend of $0.53 per share in January 2026 ...

Safety equipment manufacturer MSA Safety (NYSE:MSA) reported Q1 CY2026 results , with sales up 10% year on year to $463.6 ...

Publication of a peer-reviewed study from Alterity Therapeutic’s bioMUSE study shows an advanced MRI imaging method detects ...

The research introduces a novel memory architecture called MSA (Memory Sparse Attention). Through a combination of the Memory Sparse Attention mechanism, Document-wise RoPE for extreme context ...